Community Research and Development Information Service - CORDIS

FP7 DebugIT logo

DebugIT

Project reference: 217139
Funded under

Detecting and Eliminating Bacteria UsinG Information Technologies

From 2008-01-01 to 2012-06-30

Project details

Total cost:

EUR 8 352 757

EU contribution:

EUR 6 414 915

Coordinated in:

Belgium

Call for proposal:

FP7-ICT-2007-1See other projects for this call

Funding scheme:

CP - Collaborative project (generic)

For infectious diseases DebugIT detects patient safety related patterns and trends, acquires knowledge and uses this for better quality healthcare

In about half a century of antibiotic use, unexpected new challenges have come to light: fast emer-gence of resistances among pathogens, misuse and overuse of antibiotics; direct and indirect re-lated costs. Antimicrobial resistance results in escalating healthcare costs, increased morbidity and mortality and the emergence or reemergence of potentially untreatable pathogens. In this context of infectious diseases we will (1) detect patient safety issues, (2) learn how to prevent them and (3) actually prevent them in clinical cases. We will detect harmful patterns and trends using clinical and operational information from Clinical Information Systems (CIS). This will be
done through the ‘view’ of a virtualized Clinical Data Re-pository (CDR), featuring, transparent access to the original CIS and/or collection and aggregation of data in a local store. Text, image and structured data mining on individual patients as well as on populations will learn us informational and temporal patterns of patient harm. This knowledge will be fed into a Medical Knowledge Repository and mixed with knowledge coming from external sources (for example guidelines and evidences). After editing and validating, this knowledge will be used by a decision support and monitoring tool in the clinical environment to prevent patient safety issues and report on it.
Outcomes and benefits, both clinical and economical will be measured and reported on. Innovation within this project lays in the virtualization of Clinical Data Repository through ontology mediation, the advanced mining techniques, the reasoning engine and the consolidation of all these techniques in a comprehensive but open framework. This framework will be implemented, focused on infectious diseases, but will be applicable for all sorts of clinical cases in the future.

Objective

In about half a century of antibiotic use, unexpected new challenges have come to light: fast emer-gence of resistances among pathogens, misuse and overuse of antibiotics; direct and indirect re-lated costs. Antimicrobial resistance results in escalating healthcare costs, increased morbidity and mortality and the emergence or reemergence of potentially untreatable pathogens. In this context of infectious diseases we will (1) detect patient safety issues, (2) learn how to prevent them and (3) actually prevent them in clinical cases. We will detect harmful patterns and trends using clinical and operational information from Clinical Information Systems (CIS). This will bedone through the 'view' of a virtualized Clinical Data Re-pository (CDR), featuring, transparent access to the original CIS and/or collection and aggregation of data in a local store. Text, image and structured data mining on individual patients as well as on populations will learn us informational and temporal patterns of patient harm. This knowledge will be fed into a Medical Knowledge Repository and mixed with knowledge coming from external sources (for example guidelines and evidences). After editing and validating, this knowledge will be used by adecision support and monitoring tool in the clinical environment to prevent patient safety issues and report on it.Outcomes and benefits, both clinical and economical will be measured and reported on. Innovation within this project lays in the virtualization of Clinical Data Repository through ontology mediation, the advanced mining techniques, the reasoning engine and the consolidation of all these techniques in a comprehensive but open framework. This framework will be implemented, focused on infectious diseases, but will be applicable for all sorts of clinical cases in the future.

Related information

Open Access

Multimedia

Coordinator

AGFA HEALTHCARE N.V.
Belgium

EU contribution: EUR 1 553 339


Moutstraat 100
B-9000 GENT
Belgium
Administrative contact: Els Lion
Tel.: +32 3444 8405
Fax: +323444 8401
E-mail

Participants

GAMA/SOFIA LTD
Bulgaria

EU contribution: EUR 62 352


Tintyava
1113 SOFIA
Bulgaria
Administrative contact: Orlin Gyurov
Tel.: +3592 858 51 54
Fax: +3592 858 10 34
E-mail
HAUTE ECOLE SPECIALISEE DE SUISSE OCCIDENTALE
Switzerland

EU contribution: EUR 324 535


RUE DE LA JEUNESSE
2800 DELEMONT
Switzerland
Administrative contact: Philippe Dugerdil
Tel.: +41 22 388 17 00
Fax: +41 22 388 1740
E-mail
LES HOPITAUX UNIVERSITAIRES DE GENEVE
Switzerland

EU contribution: EUR 891 976


RUE GABRIELLE PERRET GENTIL
1205 GENEVE 14
Switzerland
Administrative contact: Antoine GEISSBUHLER
Tel.: +41223726201
Fax: +41223726255
E-mail
UNIVERSITE DE GENEVE
Switzerland

EU contribution: EUR 550 317


Rue du General Dufour
1211 GENEVE
Switzerland
Administrative contact: Alex Waehry
Tel.: +41 22 379 7560
Fax: +41 22 379 1180
E-mail
IZIP A.S.
Czech Republic

EU contribution: EUR 50 974


HVEZDOVA
14021 PRAHA 4
Czech Republic
Administrative contact: Milan Ruzicka
Tel.: +420724210805
Fax: +420221458160
E-mail
MD ACCESS AS
Czech Republic

EU contribution: EUR 61 100


Hvezdova
140 21 Prague
Czech Republic
Administrative contact: Milan Ruzicka
Tel.: +420724210805
Fax: +420221458160
E-mail
EMPIRICA GESELLSCHAFT FUER KOMMUNIKATIONS- UND TECHNOLOGIE FORSCHUNG MBH
Germany

EU contribution: EUR 530 039


OXFORDSTRASSE
53111 BONN
Germany
Administrative contact: Simon Robinson
Tel.: +49228985300
Fax: +492289853012
E-mail
UNIVERSITAETSKLINIKUM FREIBURG
Germany

EU contribution: EUR 341 503


HUGSTETTER STRASSE
79106 FREIBURG
Germany
Administrative contact: Jürgen Dreyer
Tel.: +49 761 270 20810
Fax: +49 761 270 18890
E-mail
Averbis GmbH
Germany

EU contribution: EUR 214 132


Stefan-Meier-Strasse
79104 Freiburg
Germany
Administrative contact: Philipp Daumke
Tel.: +49 761 203 97690
Fax: +49 761 203 97694
E-mail
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
France

EU contribution: EUR 397 180


101 Rue de Tolbiac
75654 PARIS
France
Administrative contact: Mihaja Auguste
Tel.: +33148073415
Fax: +33148073432
E-mail
TECHNOLOGIKO EKPEDEFTIKO IDRIMA LAMIAS
Greece

EU contribution: EUR 250 527


3 KLM PALAIAS ETHNIKIS ODOU
35100 LAMIA
Greece
Administrative contact: George Gioftsos
Tel.: +30 22310 60296
Fax: +30 22310 33945
E-mail
LINKOPINGS UNIVERSITET
Sweden

EU contribution: EUR 685 546


CAMPUS VALLA
581 83 LINKOPING
Sweden
Administrative contact: Jörgen Jonsson
Tel.: +46 13 28 67 36
Fax: +46 13 10 19 02
E-mail
UNIVERSITY COLLEGE LONDON
United Kingdom

EU contribution: EUR 501 395


Gower Street
WC1E 6BT LONDON
United Kingdom
Administrative contact: Greta Borg-Carbott
Tel.: +44 2 031083033
Fax: +44 2 078132849
E-mail
Record Number: 85484 / Last updated on: 2016-04-01